HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David W Fry Selected Research
David W Fry Research Topics
Disease
11
Neoplasms (Cancer)
07/2008 - 01/2002
3
Carcinoma (Carcinomatosis)
02/2006 - 11/2004
2
Glioblastoma (Glioblastoma Multiforme)
02/2006 - 06/2005
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2006 - 06/2005
2
Breast Neoplasms (Breast Cancer)
10/2003 - 06/2002
1
Adenocarcinoma
11/2012
1
Urinary Bladder Neoplasms (Bladder Cancer)
06/2006
1
Rhabdomyosarcoma
05/2006
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2005
1
Retinoblastoma (Glioblastoma, Retinal)
11/2004
Drug/Important Bio-Agent (IBA)
5
ErbB Receptors (EGF Receptor)
IBA
06/2005 - 01/2002
4
Canertinib (CI 1033)
IBA
06/2005 - 05/2002
3
Cyclin-Dependent Kinase 4
IBA
05/2006 - 11/2004
3
Pharmaceutical Preparations
IBA
04/2005 - 01/2002
2
Indicators and Reagents (Reagents)
IBA
06/2006 - 06/2002
2
Mitogens
IBA
05/2006 - 01/2002
2
Tyrosine (L-Tyrosine)
FDA Link
06/2005 - 05/2002
2
Phosphotransferases (Kinase)
IBA
06/2005 - 05/2002
2
Cyclin-Dependent Kinases (cdk Proteins)
IBA
04/2005 - 04/2005
2
palbociclib
IBA
04/2005 - 11/2004
2
ErbB-2 Receptor
IBA
10/2003 - 06/2002
1
Paraffin
IBA
11/2012
1
Formaldehyde (Formol)
FDA Link
11/2012
1
Gefitinib (Iressa)
FDA Link
07/2008
1
dacomitinib
IBA
07/2008
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
07/2008
1
Cyclin D
IBA
05/2006
1
Dihydrotachysterol (AT 10)
IBA
02/2006
1
pyrimidine
IBA
02/2006
1
Messenger RNA (mRNA)
IBA
06/2005
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2005
1
Salts
IBA
06/2005
1
Mesylates (Mesylate)
IBA
06/2005
1
Biomarkers (Surrogate Marker)
IBA
06/2005
1
Interleukin-8 (Interleukin 8)
IBA
06/2005
1
Retinoblastoma Protein
IBA
11/2004
1
Tyrosine Kinase Inhibitors
IBA
05/2002
1
Nucleotides
IBA
05/2002
1
geldanamycin
IBA
05/2002
1
Oncogene Proteins (Oncogene Protein)
IBA
05/2002
Therapy/Procedure
3
Oral Administration
07/2008 - 11/2004
3
Therapeutics
06/2005 - 05/2002
2
Drug Therapy (Chemotherapy)
10/2003 - 06/2002